LINDSEY CUCCHIARA: Open Payments
NPI 1669104204 · NORTH CHELMSFORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$480 in 23 payments from 12 companies in 2025. Trend: 2023 $364 · 2024 $575 · 2025 $480
Food & beverage: $480
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $95 |
| PFIZER INC. | 3 | $63 |
| Phathom Pharmaceuticals, Inc. | 4 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Lilly USA, LLC | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Lundbeck LLC | 1 | $33 |
| GlaxoSmithKline, LLC. | 1 | $32 |
| Hologic Sales and Service, LLC | 1 | $25 |
| Novo Nordisk Inc | 1 | $24 |
Products named: Kerendia, REXULTI, VOQUEZNA, PREVNAR 20, TRELEGY ELLIPTA, APTIMA, Rybelsus, KISUNLA.
Industry payments across MA — which companies pay providers there.
